mAbxience | News

INSUD PHARMA is the new name of Chemo Group

11/24/2017

Therefore, our three pharma brands, Chemo, Exeltis and mAbxience, are now grouped together under this name. This new identity is the result of the development and diversification of the company’s pharma activity. Madrid, 24 November 2017–From now on, Chemo Group, the pharmaceutical multinational that is present in over 40 countries, is going to be called […]

mAbxience analyses getting a new plant in Argentina

07/31/2017

The company is part of the multinational CHEMO group, with 40 years’ experience in the pharmaceutical industry and presence in more than 40 countries. The biotechnology company dedicated to the R&D, manufacture and commercialisation of drugs, mainly biosimilars medicines, already has an R&D centre in Spain, together with a monoclonal antibody production plant in Munro, […]

mAbxience at EACPT 2017

06/27/2017

Within the framework of the 13th Congress of the European Association of Clinical and Therapeutic Pharmacology (EACPT), held in Prague between 24th and 27th June, Dr Francisco Javier Fernández, medical advisor at mAbxience, presented the results of the population pharmacokinetic modelling the Rituximab (RTXM83) clinical study. It is an international clinical study conducted in 58 […]

BioSim visits mAbxience biosimilar production plant

04/11/2017

On April 5th we received in our plant in León the visit of a wide representation of the members of BioSim and the team of the association, headed by Joaquín Rodrigo, President, and Regina Múzquiz, Managing Director. Emmanuelle Lepine, General Manager of mAbxience, Naouel Zouaghi, Marketing and Public Affairs director and Luisa Amoedo, site director, […]

mAbxience, European success accelerating global growth

02/13/2017

mAbxience is proud to announce that it has recently received the GMP Certification from the Spanish Agency of Medicines and Health Products (AEMPS), one of the strictest and highest regarded regulatory agencies in the world. This is another success towards realization of our international growth plan.  With this certification mAbxience now has the green light […]

mAbxience, present in the World Biosimilar Congress Europe 2016

11/23/2016

Last week mAbxience took part in one of the landmark events of the biosimilar sector, the World Biosimilar Congress Europe 2016, held on 14th and 15th November in Basel, Switzerland. As every year, the most important companies of the industry attended this event, as well as representatives of official organisms of the sector and universities. […]

mAbxience, winner of the Biosimilar Initiative of the Year Award 2016

10/06/2016

mAbxience received the Biosimilar Initiative of the Year  award at the “Global Generics & Biosimilars” ceremony held on 4th October by the prestigious British “Generics Bulletin” in Barcelona, which coincided with the industrial excellence fair, the CPhI Worldwide. This publication, which organises these awards each year to highlight the industry’s achievements over the previous year, selected […]

Another participation in the CPhI

09/29/2016

mAbxience will participate for a second consecutive year in the industrial excellence fair, the CPhI, which will celebrate its next event from 4 to 6 October in Barcelona. This is one of the most important events in the pharmaceutical industry, and is attended by more than 36,000 professionals from over 150 different countries to learn […]

Biosimilars in Europe – Protagonist of BioSpain 2016

09/29/2016

What are the short- and medium-term prospects and opportunities for biosimilars? A round table, organised by the biotechnology company mAbxience, which specialises in the development of biosimilars, will answer this and many more questions. The round table will take place within the framework of BioSpain 2016, a biotechnology reference summit that will be held from […]

mAbxience at the Congress of the Spanish Society for Microbiology

09/26/2016

The 6th Congress of Industrial Microbiology and Microbial Biotechnology, which was sponsored by the Spanish Society for Microbiology (SEM), was held at the University of León from 12 to 14 September. Different scientific sessions were held during the event, which is a perfect forum for discussion among researchers and students. mAbxience was present at this […]